Brown W Virgil
Emory University School of Medicine, Atlanta, Georgia 30033, USA.
Am J Cardiol. 2008 Dec 22;102(12A):10L-13L. doi: 10.1016/j.amjcard.2008.09.068.
The microvascular complications of diabetes mellitus confer substantial morbidity and impair patient quality of life. Dyslipidemia and prolonged hyperglycemia promote an increase in oxidative stress, inflammation, and vascular damage, which together promote endothelial dysfunction and are associated with macrovascular and microvascular complications. Microalbuminuria is an early marker of diabetic nephropathy and an independent risk factor for cardiovascular disease. Diabetic nephropathy is the most common cause of end-stage renal disease in developed countries, and its prevalence is increasing. Preventing or limiting the progression of diabetic nephropathy, as demonstrated in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial, may prevent or delay renal complications, as well as convey important cardioprotective benefits in patients with type 2 diabetes.
糖尿病的微血管并发症会导致严重的发病率并损害患者的生活质量。血脂异常和长期高血糖会促使氧化应激、炎症和血管损伤增加,这些共同促进内皮功能障碍,并与大血管和微血管并发症相关。微量白蛋白尿是糖尿病肾病的早期标志物,也是心血管疾病的独立危险因素。在发达国家,糖尿病肾病是终末期肾病最常见的病因,其患病率正在上升。如非诺贝特干预与糖尿病事件降低(FIELD)试验所示,预防或限制糖尿病肾病的进展可能预防或延缓肾脏并发症,同时也能为2型糖尿病患者带来重要的心脏保护益处。